天長集團(02182.HK)獲准製造及銷售可能與客戶相似或構成競爭產品
天長集團(02182.HK)公布,於今日(14日),三間全資附屬已與一名主要客戶的兩組集團成員就電子煙產品訂立一項附件,內容有關與各對方先前訂立的製造及供應協議。對製造及供應協議的其中一項修訂為去掉獨家權條款,因此,集團獲准從事製造及銷售可能與對手方所製造產品相似或構成競爭的產品。
集團指,儘管已去掉獨家權條款,惟經考慮集團與該客戶的關係後,集團預期該客戶將繼續為集團電子煙產品的主要客戶。去掉獨家權要求允許集團透過利用經驗及既有生產廠房擴大電子煙產品的客戶基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.